Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trialSandro Pignata, I. L. Ray-Coquard, Aristotelis Bamias et al.|The Lancet Oncology|2021Cited by 148
Diagnosis of Central Precocious Puberty: Endocrine AssessmentLorenzo Iughetti, Sergio Bernasconi, Barbara Predieri et al.|Journal of Pediatric Endocrinology and Metabolism|2000Cited by 63
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsAdriano Gravina, Federica Perrone, P. Gargiulo et al.|ESMO Open|2025Cited by 8